http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20075046-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e019980e0d3964666d42b84f16f7fe2a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2007-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc14ccb16c91abd70b58a1a7e9f34a15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a847c1b9ddaa81172c6aaa853c4e973e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccfe8bec3e16fae2169d9b8706474f42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa469c582e8c6171cf9de2e2926ef6c
publicationDate 2007-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20075046-L
titleOfInvention Gastroresistant pharmaceutical formulations containing rifaximin
abstract The object of the invention is to provide pharmaceutical formulations containing rifaximin in the form of microgranules made gastroresistant with an insoluble polymer at pH values between 1.5 and 4.0 and soluble at pH values between 5.0 and 7.5, their preparation and their use in the manufacture of medicinal preparations useful in the treatment of inflammatory bowel disease (IBD) and mainly Crohn's disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20083988-L
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-345200-B1
priorityDate 2005-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411809709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436173

Total number of triples: 38.